| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-039-50 | 62135-039 | HUMAN PRESCRIPTION DRUG | Acyclovir | Acyclovir | CAPSULE | ORAL | 20220701 | N/A | ANDA | ANDA212173 | Chartwell RX, LLC | ACYCLOVIR | 200 mg/1 | 50 CAPSULE in 1 BOTTLE (62135-039-50) |
| 69117-0039-1 | 69117-0039 | HUMAN PRESCRIPTION DRUG | Acyclovir | Acyclovir | CAPSULE | ORAL | 20210312 | N/A | ANDA | ANDA212173 | YILING PHARMACEUTICAL, INC. | ACYCLOVIR | 200 mg/1 | 100 CAPSULE in 1 BOTTLE (69117-0039-1) |
| 69117-0039-2 | 69117-0039 | HUMAN PRESCRIPTION DRUG | Acyclovir | Acyclovir | CAPSULE | ORAL | 20210312 | N/A | ANDA | ANDA212173 | YILING PHARMACEUTICAL, INC. | ACYCLOVIR | 200 mg/1 | 500 CAPSULE in 1 BOTTLE (69117-0039-2) |